Other studies have shown that co-amplification of CDK4 and MDM2, with or without chromosome 1, gain results in worse overall survival while isolated chromosome 1 or 19 gain without CDK4/MDM2 co-amplification results in somewhat better survival in IDH-wildtype glioblastomas [139]. The gene discussed is IDH2; the disease is glioblastoma.